Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Torsades de pointes - a report of a case induced by caesium taken as a complementary medicine, and the literature review.

Young F, Bolt J.

J Clin Pharm Ther. 2013 Jun;38(3):254-7. doi: 10.1111/jcpt.12053. Epub 2013 Mar 14.

PMID:
23489152
2.

[A woman in her forties with cancer, syncope and spasms].

Warsame MO, Gamboa D, Nielsen EW.

Tidsskr Nor Laegeforen. 2014 Oct 14;134(19):1855-7. doi: 10.4045/tidsskr.13.1528. eCollection 2014 Oct 14. Norwegian.

3.

Life-threatening Torsades de Pointes resulting from "natural" cancer treatment.

Chan CK, Chan MH, Tse ML, Chan IH, Cheung RC, Lam CW, Lau FL.

Clin Toxicol (Phila). 2009 Jul;47(6):592-4. doi: 10.1080/15563650902997831.

PMID:
19586358
4.

Cesium chloride-induced torsades de pointes.

Wiens M, Gordon W, Baulcomb D, Mattman A, Mock T, Brown R.

Can J Cardiol. 2009 Sep;25(9):e329-31.

5.

Cesium-induced torsades de pointes.

Pinter A, Dorian P, Newman D.

N Engl J Med. 2002 Jan 31;346(5):383-4. No abstract available.

6.

Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias.

Hoehns JD, Stanford RH, Geraets DR, Skelly KS, Lee HC, Gaul BL.

Pharmacotherapy. 2001 Jul;21(7):871-83. Review.

PMID:
11444585
7.

Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.

Amankwa K, Krishnan SC, Tisdale JE.

Clin Pharmacol Ther. 2004 Mar;75(3):242-7.

PMID:
15001976
8.

Torsades de pointes ventricular tachycardia associated with overdose of astemizole.

Rao KA, Adlakha A, Verma-Ansil B, Meloy TD, Stanton MS.

Mayo Clin Proc. 1994 Jun;69(6):589-93. Review.

PMID:
8189766
9.

The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.

Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H.

J Clin Pharmacol. 2001 Dec;41(12):1310-8. Erratum in: J Clin Pharmacol 2002 May;42(5):577-9.

PMID:
11762558
10.

Probable case of torsades de pointes induced by fluconazole.

Khazan M, Mathis AS.

Pharmacotherapy. 2002 Dec;22(12):1632-7. Review.

PMID:
12495173
11.

Flecainide induced ventricular tachycardia (torsades de pointes).

Thevenin J, Da Costa A, Roche F, Romeyer C, Messier M, Isaaz K.

Pacing Clin Electrophysiol. 2003 Sep;26(9):1907-8.

PMID:
12930510
12.

Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.

K├╝hlkamp V, Mermi J, Mewis C, Seipel L.

J Cardiovasc Pharmacol. 1997 Mar;29(3):373-81.

PMID:
9125676
13.

Amiodarone and torsades de pointes in patients with advanced heart failure.

Middlekauff HR, Stevenson WG, Saxon LA, Stevenson LW.

Am J Cardiol. 1995 Sep 1;76(7):499-502.

PMID:
7653452
14.

Haloperidol-induced torsade de pointes.

O'Brien JM, Rockwood RP, Suh KI.

Ann Pharmacother. 1999 Oct;33(10):1046-50.

PMID:
10534216
15.

['Cardiac ballet' with and without amiodarone].

Balestra B, Hess T.

Schweiz Med Wochenschr. 1993 Jan 13;123(1-2):20-5. German.

PMID:
8421775
16.

Unusual case of severe arrhythmia developed after acute intoxication with tosylchloramide.

Lariccia V, Moraca A, Marini M, Nasti AA, Battistoni I, Amoroso S, Perna GP.

BMC Pharmacol Toxicol. 2013 Jan 24;14:8. doi: 10.1186/2050-6511-14-8.

17.

Ciprofloxacin-induced acquired long QT syndrome.

Prabhakar M, Krahn AD.

Heart Rhythm. 2004 Nov;1(5):624-6.

PMID:
15851230
18.
19.

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.

Hohnloser SH, Klingenheben T, Singh BN.

Ann Intern Med. 1994 Oct 1;121(7):529-35. Review.

PMID:
8067651
20.

Cesium-induced QT-interval prolongation in an adolescent.

O'Brien CE, Harik N, James LP, Seib PM, Stowe CD.

Pharmacotherapy. 2008 Aug;28(8):1059-65. doi: 10.1592/phco.28.8.1059. Review.

PMID:
18657021
Items per page

Supplemental Content

Write to the Help Desk